UpadhyayaHPDesaiahDSchuhKJet al. A review of the abuse potential assessment of atomoxetine: A nonstimulant medication for attention-deficit/hyperactivity disorder. Psychopharmacol2013; 226:189–200.
2.
CamporealeADayKARuffDet al. Profile of sexual and genitourinary treatment-emergent adverse events associated with atomoxetine treatment: A pooled analysis. Drug Saf2013; 36: 663–671.
3.
Montejo-GonzalezALLlorcaGIzquierdoJAet al. SSRI-induced sexual dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther1997; 23: 176–194.
4.
HigginsANashMLynchAM. Antidepressant-associated sexual dysfunction: Impact, effects, and treatment. Drug, Healthcare Patient Saf2010; 2: 141–150.
5.
KeltnerNLMcAfeeKMTaylorCL. Mechanisms and treatments of SSRI-induced sexual dysfunction. Perspect Psychiatr Care2002; 38: 111–116.
